SCHEMBL7440941

SCHEMBL7440941

CCc1cc(N(C)c2ccc3oc(-c4ccccc4-c4nnn[nH]4)c(Br)c3c2)n2ncc(C#N)c2n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439812 0.91 GSK3B (0.32)
SCHEMBL7436076 0.90 AGTR1 (0.31)
SCHEMBL7438628 0.90 AGTR1 (0.32)
SCHEMBL7436190 0.89 AGTR1 (0.33)
SCHEMBL7440322 0.86 AGTR1 (0.30)
SCHEMBL7445226 0.85 DPP4 (0.35)
SCHEMBL7427170 0.84 CSNK2A1 (0.35) CSNK2A1
SCHEMBL7440954 0.82 GSK3B (0.39) CSNK2A1
SCHEMBL7440070 0.81 AGTR1 (0.31)
SCHEMBL7442125 0.81 AGTR1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0628559-B1 Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF LILLY GMBH (DE) 2002-04-03 EP disclosed
US-5602136-A Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1997-02-11 US disclosed
US-5602137-A Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1997-02-11 US disclosed
US-5571813-A Fused pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1996-11-05 US disclosed
EP-0628559-A1 Pyrimidine compounds and their use as pharmaceuticals Beiersdorf-Lilly GmbH (DE) 1994-12-14 EP disclosed